findmyKOL
Clinical trialNCT06184750RecruitingPhase 2Interventional

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

SponsorNational Cancer Institute (NCI)Enrollment200Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast CarcinomaBreast Ductal Carcinoma In SituBreast Lobular Carcinoma In SituEstrogen Receptor-Positive Breast Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Arizona Cancer Center - Prevention Research Clinic

    Tucson, Arizona, United States

    Sima Ehsani Chimeh
    Recruiting
  • Northwestern University

    Chicago, Illinois, United States

    Seema A. Khan
    Recruiting
  • University of Illinois College of Medicine - Chicago

    Chicago, Illinois, United States

    Kent F. Hoskins
    Recruiting
  • University of Kansas Cancer Center

    Kansas City, Kansas, United States

    Carol J. Fabian →
    Recruiting
  • Brigham and Women'S Hospital

    Boston, Massachusetts, United States

    Elizabeth A. Mittendorf
    Recruiting
  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

    Judy E. Garber
    Recruiting
  • University of Michigan Rogel Cancer Center

    Ann Arbor, Michigan, United States

    Melissa L. Pilewskie
    Recruiting
  • Washington University School of Medicine

    St Louis, Missouri, United States

    Adetunji T. Toriola
    Recruiting
  • Case Western Reserve University

    Cleveland, Ohio, United States

    Amanda L. Amin
    Recruiting
  • Medical University of South Carolina

    Charleston, South Carolina, United States

    Kevin S. Hughes
    Recruiting
  • Ut Md Anderson Cancer Center

    Houston, Texas, United States

    Parijatham (Priya) S. Thomas
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
27 Sept 2024
Primary completion
31 Mar 2028
Completion
30 Sept 2028
Last update posted
17 Jun 2026
Registered enrollment
200
Registry id
NCT06184750
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.